US Map / Maine
State ME

Clinical Trials in Maine

Maine is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Maine and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 19 actively recruiting studies with Maine sites out of 19 registered in total. The busiest research areas in Maine are Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8. Leading sponsors running trials in the state include National Cancer Institute (NCI), Merck Sharp & Dohme LLC, Duke University. By stage, Maine trials break down as Phase 2 (2), Phase 3 (9).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
19
Recruiting Now
19
← Back to US Map
Top Conditions in Maine
Advanced Malignant Solid Neoplasm (1)Anatomic Stage III Breast Cancer AJCC v8 (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)Locally Advanced Malignant Solid Neoplasm (1)Malignant Female Reproductive System Neoplasm (1)Metastatic HER2-Negative Breast Carcinoma (1)Metastatic Malignant Solid Neoplasm (1)Recurrent Endometrial Carcinoma (1)Recurrent Fallopian Tube Carcinoma (1)Recurrent Malignant Female Reproductive System Neoplasm (1)Recurrent Malignant Solid Neoplasm (1)Recurrent Ovarian Carcinoma (1)

Frequently Asked Questions — Clinical Trials in Maine

How many clinical trials are currently recruiting in Maine?
ClinicalMetric currently tracks 19 actively recruiting clinical trials with at least one location in Maine. The total number of registered studies—including active but not currently enrolling trials—is 19. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Maine?
Maine hosts clinical trials across a broad range of medical conditions, including Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Maine serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Maine?
To join a clinical trial in Maine, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Maine maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Maine

NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
View Trial →
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
View Trial →
NCT06736574 Phase 3
Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With S...
Condition
Heart Failure
Enrollment
1,800 pts
Location
United States, Canada, China
Sponsor
Cytokinetics
View Trial →
NCT07450547 Phase 2
Recruiting
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Condition
Exocrine Pancreatic Insufficiency (EPI)
Enrollment
113 pts
Location
United States
Sponsor
Anagram Therapeutics, Inc.
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04682483 N/A
Recruiting
Cardiogenic Shock Working Group Registry
Condition
Cardiogenic Shock
Enrollment
20,000 pts
Location
United States
Sponsor
Tufts Medical Center
View Trial →
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07611110 Phase 3
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-re...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
670 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
View Trial →
NCT07318558 Phase 3
Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Can...
Condition
Ovarian Neoplasms
Enrollment
900 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
View Trial →
NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
View Trial →
NCT04088071 N/A
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Condition
Paroxysmal Atrial Fibrillation
Enrollment
20,000 pts
Location
United States, Canada
Sponsor
Heart Rhythm Clinical and Rese
View Trial →
NCT06223269 Phase 3
Recruiting
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wound...
Condition
Burns Degree Third
Enrollment
50 pts
Location
United States
Sponsor
XenoTherapeutics, Inc.
View Trial →
NCT05587569 N/A
Recruiting
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
Condition
Metatarsus Adductus
Enrollment
80 pts
Location
United States
Sponsor
Treace Medical Concepts, Inc.
View Trial →
NCT06226272 N/A
Recruiting
Clinical Outcome Measure at Stryker Spine
Condition
Degenerative Disc Disease
Enrollment
5,222 pts
Location
United States
Sponsor
VB Spine, LLC
View Trial →
NCT07680244 N/A
Recruiting
(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 an...
Condition
Epiretinal Membrane
Enrollment
400 pts
Location
United States
Sponsor
Carl Zeiss Meditec-Dublin CoCe
View Trial →
NCT06064877 Phase 3
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recur...
Condition
Metastatic Head-and-neck Squamous-cell Carcinoma
Enrollment
410 pts
Location
United States, Australia, Belgium
Sponsor
AVEO Pharmaceuticals, Inc.
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology